DE602005025940D1 - Verfahren zum testen endokriner substanz in proben - Google Patents
Verfahren zum testen endokriner substanz in probenInfo
- Publication number
- DE602005025940D1 DE602005025940D1 DE602005025940T DE602005025940T DE602005025940D1 DE 602005025940 D1 DE602005025940 D1 DE 602005025940D1 DE 602005025940 T DE602005025940 T DE 602005025940T DE 602005025940 T DE602005025940 T DE 602005025940T DE 602005025940 D1 DE602005025940 D1 DE 602005025940D1
- Authority
- DE
- Germany
- Prior art keywords
- analyte
- endocrine substance
- present
- endocrine
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005190003A JP4197180B2 (ja) | 2005-06-29 | 2005-06-29 | 検体中の内分泌物質測定方法 |
PCT/JP2005/021443 WO2007000832A1 (ja) | 2005-06-29 | 2005-11-22 | 検体中の内分泌物質測定方法。 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005025940D1 true DE602005025940D1 (de) | 2011-02-24 |
Family
ID=37595091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005025940T Active DE602005025940D1 (de) | 2005-06-29 | 2005-11-22 | Verfahren zum testen endokriner substanz in proben |
Country Status (6)
Country | Link |
---|---|
US (1) | US8058011B2 (de) |
EP (1) | EP1898215B1 (de) |
JP (1) | JP4197180B2 (de) |
AT (1) | ATE495441T1 (de) |
DE (1) | DE602005025940D1 (de) |
WO (1) | WO2007000832A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5413766B2 (ja) * | 2008-03-10 | 2014-02-12 | 株式会社シバヤギ | レプチン測定方法 |
US20110136141A1 (en) * | 2009-12-03 | 2011-06-09 | Abbott Laboratories | Peptide reagents and method for inhibiting autoantibody antigen binding |
JP5504945B2 (ja) * | 2010-02-12 | 2014-05-28 | 日東紡績株式会社 | Ftcdとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法 |
CA3000929C (en) * | 2015-10-15 | 2023-09-19 | Biocon Limited | Method for detecting neutralizing antibodies against recombinant human insulin in human serum |
JP7007278B2 (ja) * | 2016-09-06 | 2022-02-10 | 富士レビオ株式会社 | サイログロブリンの測定方法及び測定試薬 |
EP3514539A4 (de) * | 2016-09-13 | 2020-04-01 | Fujirebio Inc. | Testverfahren und testreagens für herztroponin |
JP7138627B2 (ja) * | 2017-05-17 | 2022-09-16 | 富士レビオ株式会社 | インスリンの測定方法及び測定試薬 |
WO2018221745A1 (ja) * | 2017-06-02 | 2018-12-06 | 株式会社Lsiメディエンス | 生体試料中からの標的タンパク質の抽出方法および標的タンパク質の分析方法 |
US20220196637A1 (en) * | 2019-05-24 | 2022-06-23 | Fujirebio Inc. | Method and reagent for measuring thyroglobulin |
CN111077323A (zh) * | 2020-01-12 | 2020-04-28 | 天津市宝坻区人民医院 | 消除胰岛素自身抗体干扰的胰岛素测定试剂盒 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855242A (en) * | 1986-04-14 | 1989-08-08 | Joslin Diabetes Center, Inc. | Method of detecting antibodies |
JPH0291572A (ja) | 1988-09-08 | 1990-03-30 | Nippon Dpc Corp | ウァルスdnaを用いた生物学的液体中の抗dna抗体価の測定法および測定用キット |
JPH03134567A (ja) | 1989-10-19 | 1991-06-07 | Yamasa Shoyu Co Ltd | 抗リン脂質抗体結合用担体、それを使用する免疫学的測定法およびキット |
JP2789306B2 (ja) | 1994-11-15 | 1998-08-20 | 株式会社第一ラジオアイソトープ研究所 | インスリン様成長因子の免疫学的測定方法ならびにインスリン様成長因子測定用キット |
JPH11326322A (ja) | 1998-05-06 | 1999-11-26 | Shibayagi:Kk | イヌインスリン測定用キットおよびそれを用いたイヌインスリン測定方法 |
JP3740898B2 (ja) * | 1998-07-31 | 2006-02-01 | 三菱化学株式会社 | 生理活性成分の測定法 |
DE69929059T2 (de) | 1998-07-31 | 2006-08-24 | Mitsubishi Chemical Corp. | Verfahren zum bestimmen von physiologisch aktiven komponenten |
WO2003016575A1 (en) * | 2001-08-17 | 2003-02-27 | Luminex Corporation | Method for characterizing autoimmune disorders |
US20050026826A1 (en) * | 2003-01-17 | 2005-02-03 | Margarethe Hoenig | Feline proinsulin, insulin and constituent peptides |
-
2005
- 2005-06-29 JP JP2005190003A patent/JP4197180B2/ja not_active Expired - Fee Related
- 2005-11-22 DE DE602005025940T patent/DE602005025940D1/de active Active
- 2005-11-22 EP EP05809384A patent/EP1898215B1/de not_active Not-in-force
- 2005-11-22 US US11/988,063 patent/US8058011B2/en not_active Expired - Fee Related
- 2005-11-22 AT AT05809384T patent/ATE495441T1/de not_active IP Right Cessation
- 2005-11-22 WO PCT/JP2005/021443 patent/WO2007000832A1/ja not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1898215B1 (de) | 2011-01-12 |
US20090176252A1 (en) | 2009-07-09 |
EP1898215A1 (de) | 2008-03-12 |
JP4197180B2 (ja) | 2008-12-17 |
JP2007010418A (ja) | 2007-01-18 |
US8058011B2 (en) | 2011-11-15 |
EP1898215A4 (de) | 2008-11-05 |
ATE495441T1 (de) | 2011-01-15 |
WO2007000832A1 (ja) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005025940D1 (de) | Verfahren zum testen endokriner substanz in proben | |
AR054851A1 (es) | Amperometria regulada | |
BRPI0814202A2 (pt) | Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador | |
DE602006003615D1 (de) | Glukosebiosensor und Verfahren | |
BR112014016313A8 (pt) | medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados | |
ATE520026T1 (de) | Sequenzielle analyse biologischer proben | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
DK1949849T3 (da) | Vurderingsfremgangsmåde til behandling af et glucosekoncentrationssignal | |
CL2011002228A1 (es) | Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas. | |
ATE550642T1 (de) | Verfahren zur messung von 1,5-anhydroglucitol in vollblut | |
CA2726071A1 (en) | Blood glucose monitoring device | |
HK1115636A1 (en) | Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1 | |
EP1930445A4 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
HK1133295A1 (en) | Use of protein s100a12 as a marker for colorectal cancer s100a12 | |
ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
ATE541216T1 (de) | Fluoreszenztestverfahren | |
ATE511636T1 (de) | Verfahren zum nachweis biologischer organismen mittels raman-streuung | |
WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
BR112022011676A2 (pt) | Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método | |
ATE519116T1 (de) | Verfahren zur normierung der konzentration von analyten in einer urinprobe | |
EP2573192A4 (de) | Verfahren und kit zur diagnose aim-vermittelter erkrankungen | |
HK1136873A1 (en) | Use of nnmt as a marker for lung cancer | |
ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
WO2010000467A8 (en) | Asc as a marker for lung cancer | |
HK1091540A1 (en) | Use of a virus expressing a binding moiety to measure analytes in a sample |